Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits

about

Exercise without dietary changes alleviates nonalcoholic fatty liver disease without weight loss benefits

Item

http://www.wikidata.org/entity/Q58776750

description

scientific article published on 01 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Exercise without dietary chang ...... e without weight loss benefits

@en

Exercise without dietary chang ...... e without weight loss benefits

@nl

type

Item

label

Exercise without dietary chang ...... e without weight loss benefits

@en

Exercise without dietary chang ...... e without weight loss benefits

@nl

prefLabel

Exercise without dietary chang ...... e without weight loss benefits

@en

Exercise without dietary chang ...... e without weight loss benefits

@nl

P1476

Exercise without dietary chang ...... e without weight loss benefits

@en

P2093

Duck-Pil Ok

http://www.w3.org/2001/XMLSchema#string

Kangeun Ko

http://www.w3.org/2001/XMLSchema#string

P2860

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

The role of endocannabinoids system in fatty liver disease and therapeutic potentials

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

Role of cannabinoids in the development of fatty liver (steatosis)

CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis.

Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.

Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins.

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

P2888

s12944-018-0852-z

P304

207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12944-018-0852-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ju Yong Bae

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106492106

http://www.w3.org/2001/XMLSchema#string

P698

30172252

http://www.w3.org/2001/XMLSchema#string

P921

endocrinology

P932

6119590

http://www.w3.org/2001/XMLSchema#string